Thomas E. Delea
Policy Analysis Inc. (PAI)
Four Davis Court
Brookline
MA, 02445
USA
Name/email consistency: high
- Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab. Delea, T.E., Tappenden, P., Sofrygin, O., Browning, D., Amonkar, M.M., Karnon, J., Walker, M.D., Cameron, D. Eur. J. Health. Econ (2011)
- The association between adherence to levodopa/carbidopa/entacapone therapy and healthcare utilization and costs among patients with Parkinson's disease: a retrospective claims-based analysis. Delea, T.E., Thomas, S.K., Hagiwara, M. CNS. Drugs (2011)
- Cost-effectiveness of zoledronic acid plus endocrine therapy in premenopausal women with hormone-responsive early breast cancer. Delea, T.E., Taneja, C., Sofrygin, O., Kaura, S., Gnant, M. Clin. Breast Cancer (2010)
- Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease. Delea, T.E., Thomas, S.K., Hagiwara, M., Mancione, L. Curr. Med. Res. Opin (2010)
- Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria. Delea, T.E., Sofrygin, O., Palmer, J.L., Lau, H., Munk, V.C., Sung, J., Charney, A., Parving, H.H., Sullivan, S.D. J. Am. Soc. Nephrol. (2009)
- Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders. Delea, T.E., Hagiwara, M., Phatak, P.D. Curr. Med. Res. Opin (2009)
- Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective. Delea, T.E., El-Ouagari, K., Karnon, J., Sofrygin, O. Breast Cancer Res. Treat. (2008)
- Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*. Delea, T.E., Stanford, R.H., Hagiwara, M., Stempel, D.A. Curr. Med. Res. Opin (2008)
- Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Delea, T.E., Hagiwara, M., Stanford, R.H., Stempel, D.A. Clin. Ther (2008)
- Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States. Delea, T.E., Hagiwara, M., Thomas, S.K., Baladi, J.F., Phatak, P.D., Coates, T.D. Am. J. Hematol. (2008)
- Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus. Delea, T.E., Gokhale, M., Makin, C., Hussein, M.A., Vanderpoel, J., Sandman, T., Chang, J., Sung, J., Pinkston, P., Gause, D., Jackson, M. J. Manag. Care. Pharm (2007)
- Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Delea, T.E., Edelsberg, J., Sofrygin, O., Thomas, S.K., Baladi, J.F., Phatak, P.D., Coates, T.D. Transfusion (2007)
- Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension. Delea, T.E., Taneja, C., Moynahan, A., Thomas, S.K., Frech-Tamas, F., Oster, G. Am. J. Health. Syst. Pharm (2007)
- Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective. Delea, T.E., Sofrygin, O., Thomas, S.K., Baladi, J.F., Phatak, P.D., Coates, T.D. Pharmacoeconomics (2007)
- Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer. Delea, T.E., Karnon, J., Sofrygin, O., Thomas, S.K., Papo, N.L., Barghout, V. Clin. Breast Cancer (2007)
- Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. Delea, T.E., Karnon, J., Smith, R.E., Johnston, S.R., Brandman, J., Sung, J.C., Gross, P.E. Am. J. Manag. Care (2006)
- Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. Delea, T., McKiernan, J., Brandman, J., Edelsberg, J., Sung, J., Raut, M., Oster, G. J. Support. Oncol (2006)
- Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer. Delea, T.E., McKiernan, J., Brandman, J., Edelsberg, J., Sung, J., Raut, M., Oster, G. J. Thorac. Oncol (2006)
- Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate. Delea, T.E., Stanford, R., Hagiwara, M., Edelsberg, J.S., Oster, G. Int. J. Cardiol. (2005)
- Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention. Delea, T.E., Jacobson, T.A., Serruys, P.W., Edelsberg, J.S., Oster, G. Ann. Pharmacother (2005)
- The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Delea, T., Langer, C., McKiernan, J., Liss, M., Edelsberg, J., Brandman, J., Sung, J., Raut, M., Oster, G. Oncology (2004)
